Organon Partially Exempts Missouri, Minnesota Providers from 340B Contract Pharmacy Restrictions
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...]
*Sign up for news summaries and alerts from 340B Report